|
17
|
99
|
3dcrA |
X-ray structure of hiv-1 protease and hydrated form of ketomethylene isostere inhibitor |
|
19
|
99
|
3d3tA |
Crystal structure of hiv-1 crf01_ae in complex with the substrate p1-p6 |
|
18
|
99
|
3d1zA |
Crystal structure of hiv-1 mutant i54m and inhibitor darunavir |
|
18
|
99
|
3d20A |
Crystal structure of hiv-1 mutant i54v and inhibitor darunavia |
|
18
|
99
|
3d1xA |
Crystal structure of hiv-1 mutant i54m and inhibitor saquinavir |
|
17
|
99
|
3cyxA |
Crystal structure of hiv-1 mutant i50v and inhibitor saquinavira |
|
17
|
99
|
3d1yA |
Crystal structure of hiv-1 mutant i54v and inhibitor saquina |
|
19
|
99
|
3cktA |
Hiv-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (orthorombic space group) |
|
16
|
99
|
3bxrA |
Crystal structures of highly constrained substrate and hydrolysis products bound to hiv-1 protease. implications for catalytic mechanism |
|
19
|
99
|
3bvaA |
Cystal structure of hiv-1 active site mutant d25n and p2-nc analog inhibitor |
|
17
|
99
|
3bvbA |
Cystal structure of hiv-1 active site mutant d25n and inhibitor darunavir |
|
17
|
99
|
3bxsA |
Crystal structures of highly constrained substrate and hydrolysis products bound to hiv-1 protease. implications for catalytic mechanism |
|
16
|
99
|
3bc4A |
I84v hiv-1 protease in complex with a pyrrolidine diester |
|
17
|
99
|
3bheA |
Hiv-1 protease in complex with a three armed pyrrolidine derivative |
|
17
|
99
|
3bgcA |
Hiv-1 protease in complex with a benzyl decorated oligoamine |
|
16
|
99
|
3bgbA |
Hiv-1 protease in complex with a isobutyl decorated oligoamine |
|
18
|
99
|
3b7vA |
Hiv-1 protease complexed with gem-diol-amine tetrahedral intermediate nlltqi |
|
17
|
99
|
3b80A |
Hiv-1 protease mutant i54v complexed with gem-diol-amine intermediate nlltqi |
|
16
|
99
|
3aidA |
A new class of hiv-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere |
|
17
|
99
|
3a2oA |
Crystal structure of hiv-1 protease complexed with kni-1689 |
|
16
|
99
|
2zyeA |
Structure of hiv-1 protease in complex with potent inhibitor kni-272 determined by neutron crystallography |
|
18
|
99
|
2z4oA |
Wild type hiv-1 protease with potent antiviral inhibitor grl-98065 |
|
20
|
99
|
2z54A |
The influence of i47a mutation on reduced susceptibility to the protease inhibitor lopinavir |
|
20
|
99
|
2zgaA |
Hiv-1 protease in complex with a dimethylallyl decorated pyrrolidine based inhibitor (hexagonal space group) |
|
16
|
99
|
2xyfA |
Hiv-1 inhibitors with a tertiary-alcohol-containing transition-state mimic and various p2 and p1 prime substituents |
|
16
|
99
|
2xyeA |
Hiv-1 inhibitors with a tertiary-alcohol-containing transition-state mimic and various p2 and p1 prime substituents |
|
49
|
203
|
2whhA |
Hiv-1 protease tethered dimer q-product complex along with nucleophilic water molecule |
|
16
|
99
|
2wl0A |
Hiv-1 protease inhibitors containing a tertiary alcohol in the transition-state mimic with improved cell-based antiviral activity |
|
16
|
99
|
2wkzA |
Hiv-1 protease inhibitors containing a tertiary alcohol in the transition-state mimic with improved cell-based antiviral activity |
|
16
|
99
|
2uxzA |
Two-carbon-elongated hiv-1 protease inhibitors with a tertiary- alcohol-containing transition-state mimic |
|
15
|
99
|
2uy0A |
Two-carbon-elongated hiv-1 protease inhibitors with a tertiary- alcohol-containing transition-state mimic |
|
25
|
124
|
2rspA |
Structure of the aspartic protease from rous sarcoma retrovirus refined at 2 angstroms resolution |
|
15
|
99
|
2upjA |
Hiv-1 protease complex with u100313 ([3-[[3-[cyclopropyl [4-hydroxy-2oxo-6-[1-(phenylmethyl)propyl]-2h-pyran-3-yl] methyl]phenyl]amino]-3-oxo-propyl]carbamic acid tert-butyl ester) |
|
19
|
99
|
2rkfA |
Hiv-1 pr resistant mutant + lpv |
|
16
|
99
|
2samA |
Structure of the protease from simian immunodeficiency virus: complex with an irreversible non-peptide inhibitor |
|
19
|
100
|
2rkgA |
Hiv-1 pr resistant mutant + lpv |
|
17
|
99
|
2r5pA |
Crystal structure analysis of hiv-1 subtype c protease complexed with indinavir |
|
17
|
99
|
2r8nA |
Structural analysis of the unbound form of hiv-1 subtype c protease |
|
17
|
99
|
2r5qA |
Crystal structure analysis of hiv-1 subtype c protease complexed with nelfinavir |
|
16
|
99
|
2r3wA |
I84v hiv-1 protease in complex with a amino decorated pyrrolidine-based inhibitor |
|
18
|
99
|
2r3tA |
I50v hiv-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor |
|
17
|
99
|
2r43A |
I50v hiv-1 protease in complex with an amino decorated pyrrolidine-based inhibitor |
|
16
|
99
|
2r38A |
I84v hiv-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor |
|
18
|
99
|
2qi3A |
Crystal structure of protease inhibitor, mit-2-ad94 in complex with wild type hiv-1 protease |
|
19
|
99
|
2qciA |
Hiv-1 protease mutant d30n with potent antiviral inhibitor grl-98065 |
|
17
|
99
|
2qnnA |
Hiv-1 protease in complex with a multiple decorated pyrrolidine-based inhibitor |
|
18
|
99
|
2qi0A |
Crystal structure of protease inhibitor, mit-1-kk80 in complex with wild type hiv-1 protease |
|
18
|
99
|
2qd8A |
Hiv-1 protease mutant i84v with potent antiviral inhibitor grl-98065 |
|
18
|
99
|
2qhyA |
Crystal structure of protease inhibitor, mit-1-ac86 in complex with wild type hiv-1 protease |
|
17
|
99
|
2qakA |
Hiv-1 pr mutant in complex with nelfinavir |
